Talis Biomedical Corporation (TLIS)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
At close: Dec 3, 2025
Talis Biomedical Market Cap
Talis Biomedical has a market cap or net worth of $2.92 million as of December 5, 2025. Its market cap has decreased by -79.99% in one year.
Market Cap
2.92M
Enterprise Value
-38.15M
Revenue
408.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.60
Market Cap Chart
Since February 12, 2021, Talis Biomedical's market cap has decreased from 652.79M to 2.92M, a decrease of -99.55%. That is a compound annual growth rate of -67.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 2.92M | -9.04% |
| Dec 31, 2024 | 3.21M | -76.37% |
| Dec 29, 2023 | 13.57M | 13.66% |
| Dec 30, 2022 | 11.94M | -88.68% |
| Dec 31, 2021 | 105.42M | -83.85% |
| Feb 12, 2021 | 652.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |